These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 1333544
21. [Advances in the treatment of pulmonary tuberculosis in children]. Alcaide Megias J, Altet Gómez MN. An Esp Pediatr; 1983 Sep; 19 Suppl 19():12-7. PubMed ID: 6419658 [No Abstract] [Full Text] [Related]
22. [New tuberculostatics under experiment. Results and prospects]. Anastasatu C. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989 Sep; 38(2):99-107. PubMed ID: 2555909 [No Abstract] [Full Text] [Related]
23. [Bacteriological and clinical aspects of the restoration of drug sensitivity of formerly resistant Mycobacterium cultures]. Rudoĭ NM, Bochkov EN. Probl Tuberk; 1973 Sep; 51(10):24-6. PubMed ID: 4206103 [No Abstract] [Full Text] [Related]
24. [Comparison of laboratory and clinical antitubercular agent sensitivity tests]. Popovic J, Praso R, Stosic Z, Davidovic C. Plucne Bolesti Tuberk; 1971 Sep; 23(4):333-8. PubMed ID: 5004987 [No Abstract] [Full Text] [Related]
25. [Aspects of chemoresistance of Koch bacillus in the period 1971-1980 in the Constanţa tuberculosis outpatient clinic]. Toldişan V, Didilescu C, Filip G. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983 Sep; 32(1):53-7. PubMed ID: 6312536 [No Abstract] [Full Text] [Related]
26. [Frequency and clinical importance of primary pharmacoresistance of Mycobacteria in patients with tuberculosis of the lungs]. Bibik NF. Probl Tuberk; 1972 Sep; 50(8):20-5. PubMed ID: 4626690 [No Abstract] [Full Text] [Related]
27. [Clinical aspects of secondary resistance in pulmonary tuberculosis]. Gugić B. Plucne Bolesti; 1985 Sep; 37(1-2):22-7. PubMed ID: 3934690 [No Abstract] [Full Text] [Related]
28. [Clinical study on tuberactinomycin, a new antibiotic]. Osato T, Toyoara M. Kekkaku; 1971 May; 46(3):59-63. PubMed ID: 4324041 [No Abstract] [Full Text] [Related]
29. [Resistance and virulence of mycobacteria. Clinical and experimental studies]. Lucchesi M. Ftiziologia; 1971 May; 20(4):401-4. PubMed ID: 5005707 [No Abstract] [Full Text] [Related]
30. [Incidence of primary resistance to antitubercular agents in the Toulouse area]. Puel J, Galtier M, Lareng MB, Delaude A. Arch Monaldi; 1972 May; 27(4):418-25. PubMed ID: 4217598 [No Abstract] [Full Text] [Related]
31. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria]. Fomicheva NI, Terentieva AS. Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645 [No Abstract] [Full Text] [Related]
32. [Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis]. Korotaev GA, Kozulitsyna TI, Tret'iakova EA, Mamed'iarova FA. Probl Tuberk; 1986 Dec; (7):32-6. PubMed ID: 3094001 [No Abstract] [Full Text] [Related]
33. [A method for the determination of the resistance of Mycobacterium tuberculosis to classical antitubercular drugs in percentages]. Zduńczyk-Pawelek H, Kostrzewska K, Blitek-Golc D. Gruzlica; 1966 Feb; 34(2):89-94. PubMed ID: 4957541 [No Abstract] [Full Text] [Related]
36. [The phenomenon of primary mycobacterial resistance in the records of the Clinica Tisiologica di Parma]. Di Perna A, Rabinovici A. Arch Monaldi; 1972 Aug; 27(4):495-500. PubMed ID: 4217602 [No Abstract] [Full Text] [Related]
40. [Terminal causes of death in patients suffering from pulmonary tuberculosis in relation to the drug sensitivity of the strains of Mycobacterium tuberculosis]. Daddi G, Lucchesi M, Mancini P, Rossi P, Sbampato M, Storniello G. Ann Ist Carlo Forlanini; 1969 Aug; 29(4):339-48. PubMed ID: 5004332 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]